熱門資訊> 正文
德意志银行升级了阿卡迪亚医疗保健的风险回报状况
2024-04-25 23:05
- Deutsche Bank upgraded behavioral healthcare provider Acadia Healthcare (NASDAQ:ACHC) to Hold from Sell on Thursday, citing a neutral risk-reward setup following a recent decline in its share price.
- The firm noted that ACHC stock has lost ~9% this year amid a series of issues, while its for-profit rivals, such as HCA Healthcare (HCA), have added ~18%. Yet, it sees a neutral risk/reward profile at these levels, which leads to the upgrade.
- However, Deutsche Bank continues to flag concerns over Acadia’s (ACHC) EBITDA narrative if the government eliminates its competitive advantage in the CTC division, which operates comprehensive treatment centers (CTC), targeting substance use disorders.
- The firm expects further headwinds if Congress clears the Modernizing Opioid Treatment Act, targeted at increasing the availability of opioid overdose therapy, methadone. Deutsche Bank maintained its $70 price target on Acadia (ACHC).
More on Acadia Healthcare
- Acadia Healthcare Company, Inc. (ACHC) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Acadia Healthcare
- Historical earnings data for Acadia Healthcare
- Financial information for Acadia Healthcare
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
